Display options
Cite
Nikodimopoulou M, Liakos S. Secondary hyperparathyroidism and target organs in chronic kidney disease. Hippokratia. 2011;15:33-8
Nikodimopoulou, M., & Liakos, S. (2011). Secondary hyperparathyroidism and target organs in chronic kidney disease. Hippokratia, 1533-8.
Nikodimopoulou, M, and Liakos, S. "Secondary hyperparathyroidism and target organs in chronic kidney disease." Hippokratia vol. 15 (2011): 33-8.
Nikodimopoulou M, Liakos S. Secondary hyperparathyroidism and target organs in chronic kidney disease. Hippokratia. 2011 Jan;15:33-8. PMID: 21897756; PMCID: PMC3139677.
Copy Download .nbib Format: NLM
Share it on

Hippokratia. 2011 Jan;15:33-8.

Secondary hyperparathyroidism and target organs in chronic kidney disease.

Hippokratia

M Nikodimopoulou, S Liakos

Affiliations

  1. 1 Propedeutic Medical Department, AHEPA Hospital, Aristotles University of Thessaloniki,Greece.

PMID: 21897756 PMCID: PMC3139677

Abstract

Secondary hyperparathyroidism (SHPT) is a common disorder in patients with chronic kidney disease (CKD) and is characterized by excessive serum parathyroid hormone (PTH) levels, parathyroid hyperplasia and an imbalance in calcium and phosphorus metabolism. Secondary hyperparathyroidism develops early in the course of CKD and becomes more prominent as kidney function declines.PTH is a major uremic toxin and may be responsible for long-term consequences that include renal osteodystrophy, severe vascular calcifications, alterations in cardiovascular structure and function, immune dysfunction, and anemia. These adverse effects may contribute to an increased risk of cardiovascular morbidity and mortality among end-stage renal failure patients.

Keywords: cardiovascular disease; iPTH; vitamin D

References

  1. J Clin Endocrinol Metab. 2001 Mar;86(3):1212-21 - PubMed
  2. Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9733-7 - PubMed
  3. J Bone Miner Res. 1993 Sep;8(9):1045-52 - PubMed
  4. Lab Invest. 1994 Feb;70(2):138-51 - PubMed
  5. Radiology. 2004 Feb;230(2):491-2 - PubMed
  6. Clin Endocrinol (Oxf). 1999 Mar;50(3):321-8 - PubMed
  7. Ren Fail. 2001 Jan;23(1):115-26 - PubMed
  8. J Clin Endocrinol Metab. 2000 May;85(5):1815-21 - PubMed
  9. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8097-101 - PubMed
  10. Peptides. 2002 Jan;23(1):79-85 - PubMed
  11. Eur J Radiol. 2003 May;46(2):85-95 - PubMed
  12. J Clin Endocrinol Metab. 1980 Jul;51(1):130-4 - PubMed
  13. Eur J Clin Invest. 2006 Aug;36 Suppl 2:13-22 - PubMed
  14. Cardiology. 2000;93(4):229-33 - PubMed
  15. J Am Soc Nephrol. 1991 Jul;2(1):2-12 - PubMed
  16. J Clin Invest. 1981 Feb;67(2):563-8 - PubMed
  17. J Endocrinol. 2001 Aug;170(2):433-40 - PubMed
  18. Am J Kidney Dis. 1998 Apr;31(4):607-17 - PubMed
  19. Am J Kidney Dis. 2000 Aug;36(2):415-8 - PubMed
  20. Kidney Int. 1987 Dec;32(6):900-7 - PubMed
  21. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1387-91 - PubMed
  22. Semin Nephrol. 1999 Mar;19(2):115-22 - PubMed
  23. Kidney Int. 1976 Apr;9(4):355-62 - PubMed
  24. Kidney Int. 1995 Jan;47(1):186-92 - PubMed
  25. Semin Nephrol. 1994 May;14(3):219-31 - PubMed
  26. Am J Nephrol. 1994;14(1):41-6 - PubMed
  27. Eur Radiol. 1997;7(5):708-17 - PubMed
  28. Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16810-5 - PubMed
  29. Endocr Rev. 1991 Aug;12(3):291-301 - PubMed
  30. Am J Kidney Dis. 1998 Dec;32(6):992-9 - PubMed
  31. Cytokine. 1994 Jan;6(1):87-91 - PubMed
  32. N Engl J Med. 1998 Sep 10;339(11):733-8 - PubMed
  33. Kidney Int. 1995 Apr;47(4):1182-6 - PubMed
  34. Biochem Biophys Res Commun. 1992 Jun 30;185(3):881-6 - PubMed
  35. Kidney Int. 1995 Oct;48(4):1324-31 - PubMed
  36. J Am Podiatr Med Assoc. 1997 May;87(5):238-40 - PubMed
  37. J Neurosurg. 1999 Apr;90(2 Suppl):242-6 - PubMed
  38. J Clin Invest. 1983 Jun;71(6):1806-21 - PubMed
  39. Am J Kidney Dis. 1993 Jun;21(6):573-92 - PubMed
  40. J Clin Endocrinol Metab. 1988 Nov;67(5):876-81 - PubMed
  41. J Clin Endocrinol Metab. 1997 Jan;82(1):106-12 - PubMed
  42. Arch Orthop Trauma Surg. 2003 Feb;123(1):51-3 - PubMed
  43. J Clin Invest. 1978 Aug;62(2):425-35 - PubMed
  44. Am J Physiol. 1995 Jul;269(1 Pt 1):G103-9 - PubMed
  45. Endocrinology. 1995 Apr;136(4):1419-25 - PubMed
  46. Nephrol Dial Transplant. 1996 May;11(5):786-90 - PubMed
  47. Lancet. 1981 Dec 12;2(8259):1321-3 - PubMed
  48. Kidney Int. 2000 Jul;58(1):396-9 - PubMed
  49. Endocrinology. 2001 Jul;142(7):3135-41 - PubMed
  50. Curr Diab Rep. 2004 Feb;4(1):31-6 - PubMed
  51. Kidney Int. 1995 May;47(5):1434-42 - PubMed
  52. Endocrinology. 1990 Aug;127(2):942-8 - PubMed
  53. J Clin Invest. 1966 Oct;45(10):1608-14 - PubMed
  54. Kidney Int. 1999 Sep;56(3):1084-93 - PubMed
  55. Cardiovasc Res. 1998 Jan;37(1):34-41 - PubMed
  56. Metabolism. 1978 Dec;27(12 Suppl 2):1866-80 - PubMed
  57. Nutr Rev. 1998 Feb;56(2 Pt 2):S4-10; discussion S 54-75 - PubMed
  58. Adv Ren Replace Ther. 1997 Jul;4(3):234-48 - PubMed
  59. Am J Physiol. 1996 Dec;271(6 Pt 2):F1114-22 - PubMed
  60. Nephrol Dial Transplant. 1996;11 Suppl 3:37-42 - PubMed
  61. Am J Kidney Dis. 1999 Jan;33(1):73-81 - PubMed
  62. N Engl J Med. 1978 May 4;298(18):1000-3 - PubMed
  63. Arq Bras Endocrinol Metabol. 2006 Oct;50(5):963-7 - PubMed
  64. J Am Coll Cardiol. 2007 Sep 25;50(13):1238-45 - PubMed

Publication Types